483
ACS DOBFAR SPAFDA 483 - ACS DOBFAR SPA - October 29, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of ACS Dobfar SpA, a sterile drug manufacturer in Castellalto, Italy, revealed deficiencies in procedures designed to prevent microbial contamination of sterile drug products. Observations included degrading gaskets on conveyor wheels and damaged identification labels on electrical wires within manufacturing areas. These findings indicate a need for improved adherence to sterile manufacturing practices.
Open in Dashboard
ID · ea51aa34-127c-4143-906e-6aca74b897f0